Georgia's Online Cancer Information Center

Find A Doctor

Kathleen A. Long MD
Kathleen A. Long MD
Northwest Georgia Oncology Centers, P.C.
www.ngoc.com

Kathleen A. Long MD

Specialty
Medical Oncology, Hematology, Internal Medicine / Board Certified
Trial Cancers
Breast Cancer, Leukemia, Lung Cancer, Lymphoma, Non-Hodgkin Lymphoma, Ovarian Cancer, Solid Tumor
Affiliations
Northside Hospital Cherokee

Active Clinical Trial Sites in Georgia

Cartersville Medical Center

960 Joe Frank Harris Parkway
Cartersville, GA 30120
770-382-1530 (p)
www.cartersvillemedical.com

driving directions



Northwest Georgia Oncology Centers - Paulding

144 Bill Carruth Parkway
Suite 3100
Hiram, GA 30141
678-363-1940 (p)
678-581-7110 (f)
www.ngoc.com

driving directions

Clinical Trials
An Open-Label, Multicenter Extension Study of Trastuzumab-MCC-DM1 (T-DM1) Administered as a Single Agent or in Combination With Other Anti-Cancer Therapies in Patients Previously Treated With the Equivalent T-DM1 Regimen in a Genentech and/or F. Hoffmann-La Roche Ltd.-Sponsored T-DM1 Study
Cancer Type: Breast Cancer

Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Of Fulvestrant (Faslodex®) With Or Without PD-0332991 (Palbociclib) +/- Goserelin In Women With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer Whose Disease Progressed After Prior Endocrine Therapy
Cancer Type: Breast Cancer

Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations. (OlympiAD)
Cancer Type: Breast Cancer

Connect® MDS/AML: The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry
Cancer Type: Leukemia

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer Who Either Relapsed or Were Refractory to Prior Chemotherapy
Cancer Type: Lung Cancer

A Study of Obinutuzumab, Polatuzumab Vedotin, and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)
Cancer Type: Lymphoma

A Phase 3B Randomized Study of Lenalidomide (CC-5013) Plus Rituximab Maintenance Therapy Followed by Lenalidomide Single-agent Maintenance Versus Rituximab Maintenance in Subjects With Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma
Cancer Type: Non-Hodgkin Lymphoma

A Phase I, Open-label, Multiple-ascending Dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological and Clinical Activity of MSB0010718C in Subjects With Metastatic or Locally Advanced Solid Tumors and Expansion to Selected Indications
Cancer Type: Ovarian Cancer

Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 6 - BGJ398 for Patients With Tumors With FGFR Genetic Alterations
Cancer Type: Solid Tumor


Piedmont Hospital - Atlanta

1968 Peachtree Road, NW
Atlanta, GA 30309
404-605-5000 (p)
www.piedmont.org

driving directions



WellStar Kennestone Hospital

677 Church Street
Marietta, GA 30060
770-793-5000 (p)
www.wellstar.org

driving directions

**GeorgiaCancerInfo is not a medical practice. This is an informational web site provided by Georgia CORE, a nonprofit striving to provide current and comprehensive information on cancer care in Georgia through this website. If you find erroneous or missing information, please contact us.
Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.